Zerion Pharma A/S

Company's own description on virk.dk

Zerion Pharma A/S (“Zerion” or “the Company”) is a drug development company, based in Copenhagen. The Company was founded in January 2019 as a spinout from the University of Copenhagen based on a decade of research. ​ ​Zerion has developed a formulation technology, Dispersome®, that enables poorly soluble drugs to become effective pharmaceutical products. The Company applies the technology to 1) improve existing drug products, thereby building its own pipeline of product candidates and 2) partner with major pharmaceutical and biotech companies to solve problems with solubility and bioavailability in their new pharmaceutical candidates (NCEs). ​​Zerion’s R&D activities comprise firstly in-house lab work with the aim to develop better formulations of new and existing drugs. The Company’s research labs are located at the incubator centre, Symbion, where the Company employs about 10 scientists and technicians. Secondly, Zerion conducts external pre-clinical and eventually clinical studies with selected drug candidates which incorporate the Dispersome® technology.